Clovis Oncology Inc (OTC Pink - Current Information:CLVSQ)
| 0.1088 Delayed Data As of Mar 31 |  -0.0001 / -0.09%Today’s Change | 0.04 Today|||52-Week Range 3.25 | +106.26% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 278.8M | 216.2M | 464.2M | 221.9M | |
| Short Term Investment Cash | -203.9M | -62.6M | 248.0M | -242.3M | ||
| Cash & Short Term Investments | 528.6M | 266.2M | 563.7M | 520.1M | ||
| Receivables | Receivables | 5.3M | 3.4M | 8.2M | 15.2M | |
| Inventories | Inventories | 0.00 | 0.00 | 48.0M | 27.1M | |
| Current Assets | Prepaid Expenses | 5.6M | 9.8M | 6.8M | 9.0M | |
| Other Current Assets | 199.0K | 90.0K | 187.0K | 956.0K | ||
| Current Assets | 539.7M | 279.4M | 626.9M | 572.3M | ||
| Total Assets | Property, Plant and Equipment - Gross | 6.7M | 7.1M | 7.7M | 31.8M | |
| Depreciation | -1.8M | -2.7M | -3.7M | -5.3M | ||
| Intangible Assets | 160.8M | 78.2M | 84.8M | 115.0M | ||
| Other Assets | 168.7M | 80.7M | 104.3M | 264.7M | ||
| Total Assets | 713.4M | 364.6M | 735.2M | 865.3M | ||
| Liabilities | Accounts Payable | 11.3M | 10.9M | 15.1M | 28.5M | |
| Short Term Debt | 0.00 | 0.00 | 22.0M | 1.0M | ||
| Accrued Expenses | 54.0M | 36.7M | 25.7M | 41.9M | ||
| Other Current Liabilities | 56.1M | 38.8M | 30.5M | 44.6M | ||
| Other Liabilities | 75.6M | 65.6M | 81.5M | 125.7M | ||
| Total Liabilities | Long Term Debt | 279.9M | 281.1M | 282.4M | 575.5M | |
| Deferred Taxes | -31.1M | 0.00 | -- | 0.00 | ||
| Other Liabilities | 0.00 | 20.1M | 0.00 | 0.00 | ||
| Total Liabilities | 412.7M | 368.2M | 367.6M | 718.8M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 300.7M | -3.6M | 367.6M | 146.5M | ||
| Total Shareholder Equity | 300.7M | -3.6M | 367.6M | 146.5M | ||
| Share Information | Common Shares Outstanding | 38.4M | 38.7M | 50.6M | 52.8M | |
| Addtl. Info. | No data currently available for this section. | |||||
